A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040
Autoimmunity Reviews · 2023
DOI: 10.1016/j.autrev.2023.103407 ↗Kurz gefasst
Leserbrief in der Zeitschrift Autoimmunity Reviews, 2023. Verfasst von Da-Peng Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Head and Neck Surgery, The Affiliated Bozhou Hospital of Anhui Medical University, China; Scientific research and exper…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Multiple Sclerosis, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 13 Literaturangaben.
Abstract (Originalsprache)
AIM: To analyze the global incidence trends for four autoimmune diseases (ADs) including rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis (MS) and psoriasis from 1990 to 2019, and further predict their changes to 2040 at global, regional, and national levels. METHODS: The estimates and 95% uncertainty intervals (UIs) for case number and agestandardized incidence rate (ASIR) of RA, IBD, MS and psoriasis were derived from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Estimated annual percentage change (EAPC) was utilized to quantify the global incidence trends for RA, IBD, MS and psoriasis from 1990 to 2019. Furthermore, a log-linear age-period-cohort model was adopted to predict the new case number and incidence rates for these four ADs through 2040. RESULTS: From 1990 to 2019, the global ASIR rose significantly for RA (EAPC = 0.30%, 95% CI: 0.26 to 0.34) whereas declined significantly for IBD (EAPC = -0.60%, 95% CI: -0.72 to - 0.48), MS (EAPC = -0.19%, 95% CI: -0.24 to -0.13) and psoriasis (EAPC = -0.77%, 95% CI: -0.78 to -0.76). From 2020 to 2040, the global ASIR of RA, IBD, and psoriasis was predicted to decrease whereas the global ASIR of MS was predicted to increase, with continuous increasing case number of all these diseases. Furthermore, the predicted incidence trends of these four ADs varied significantly across 195 countries and territories, with a prominent higher burden in high-income North America and Western Europe. CONCLUSIONS: There are strong heterogeneities in the global incidence trends (1990-2019) and predicted changes (2020-2040) of ADs across the world, highlighting prominent challenges in the control of ADs, including both growing case number and distributive disparities of these diseases worldwide, which may be instructive for better public health policy establishment and healthcare resource allocation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology, Head and Neck Surgery, The Affiliated Bozhou Hospital of Anhui Medical University, China; Scientific research and experiment center, The Affiliated Bozhou Hospital of Anhui Medical Universi…
- Department of Otolaryngology, Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, 218 Jixi Road, Hefei, Anhui, China.
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, China.
- Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, Anhui, China; Department of clinical medicine, The Second School of Clinical Medicine, Anhui Medical Unive…
- Department of clinical medicine, The Second School of Clinical Medicine, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, China.
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, China. Electronic address: panhaifeng@ahmu.edu.cn.
Zitieren
APA
Li, D. P., Han, Y. X., He, Y. S., Wen, Y., Liu, Y. C., Fu, Z. Y., Pan, H. F., & Cao, F. (2023). A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2023.103407
Vancouver
Li DP, Han YX, He YS, Wen Y, Liu YC, Fu ZY, et al. A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040. Autoimmunity Reviews. 2023. doi:10.1016/j.autrev.2023.103407
BibTeX
@article{Li2023,
author = {Li, Da-Peng and Han, Yan-Xun and He, Yi-Sheng and Wen, Yu and Liu, Yu-Chen and Fu, Zi-Yue and Pan, Hai-Feng and Cao, Fan},
title = {A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040},
journal = {Autoimmunity Reviews},
year = {2023},
doi = {10.1016/j.autrev.2023.103407}
}
EUVIMED